Proactive surveillance of foodborne bioactives by integrated dietary exposure and urinary excretion assessment
Related Experiment Video
Updated: Apr 4, 2026

'Boden Food Plate': Novel Interactive Web-based Method for the Assessment of Dietary Intake
Published on: September 18, 2018
1Doping Control Center, Korea Institute of Science and Technology, Seoul, Republic of Korea. oneappeal@kist.re.kr.
Abstract:
Unintentional ingestion of pharmacologically-active substances through foods and dietary supplements presents growing challenges for food safety and anti-doping regulation. We developed a high-throughput LC-MS/MS platform to simultaneously screen 331 compounds and quantify 214 analytes, with matrix-matched validation in pork, oat, and beverage. The method showed applicability across ten food types and was applied to seventy-eight commercial products, revealing frequent detection of bioactives such as octopamine, coclaurine, and olodaterol. Simulations of dietary exposure and urinary excretion demonstrated that some of these substances exceed World Anti-Doping Agency reporting thresholds under realistic consumption scenarios, risking adverse analytical findings even without intentional use. This study presents an integrated framework linking analytical detection with exposure assessment, enabling proactive identification of regulatory-relevant substances across complex food matrices. The approach provides a practical tool for monitoring foodborne chemical exposure and supports risk management for both the general population and athletes subject to strict doping control standards.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
14:48Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis
Published on: May 8, 2021
Related Concept Videos
Measurement of Bioavailability: Pharmacokinetic Methods
Investigation of Disease Outbreaks
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Measurement of Bioavailability: Pharmacodynamic Methods
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems